Eugene Schneider Insider Trades & Stock Holdings

EVP, Chf Clinical Develop Ofcr · Ionis Pharmaceuticals, Inc. · Latest filing Jun 26, 2026

Eugene Schneider, EVP, Chf Clinical Develop Ofcr at Ionis Pharmaceuticals, Inc. has 1 Form 4 trade on file since Jun 26, 2026. Latest filing: acquired 26K shares of $IONS on Jun 26, 2026 at $60.89.

Trades on file

1

Open-market bought

$0

Open-market sold

$0

Net open-market

$0

Latest filing

Jun 26, 2026

All insider trades by Eugene Schneider

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 26, 2026	$IONS	Buy (Option exercise)	26K	$60.89	$1.58M			+2.5%	-31.1%		EVP, Chf Clinical Develop Ofcr		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Eugene Schneider traded

• $IONS

Frequently asked questions

What was Eugene Schneider's latest insider trade?

acquired 26K shares of $IONS on Jun 26, 2026 at $60.89.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.